Grey Zone Lymphoma
Also known as: Gray Zone Lymphoma / Gray-zone Lymphoma / B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma (disorder)
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB06769 | Bendamustine | 1 | Active Not Recruiting | 1 |
DB06769 | Bendamustine | 1 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 | Active Not Recruiting | 1 |
DB01073 | Fludarabine | 1 | Recruiting | 1 |
DB06769 | Bendamustine | 2 | Withdrawn | 1 |
DB08870 | Brentuximab vedotin | 2 | Withdrawn | 1 |
DB16382 | Brentuximab vedotin | 2 | Withdrawn | 1 |
DB00958 | Carboplatin | 2 | Not Yet Recruiting | 1 |
DB00773 | Etoposide | 2 | Not Yet Recruiting | 1 |
DB01590 | Everolimus | 2 | Completed | 1 |
DB09037 | Pembrolizumab | 2 | Completed | 1 |
DB00073 | Rituximab | 2 | Active Not Recruiting | 1 |
DB00073 | Rituximab | 2 | Completed | 1 |
DB00073 | Rituximab | 2 | Withdrawn | 1 |